反応式
NC1[N:10]=[CH:9][N:8]=[C:7]2[C:3]=1[N:4]=[CH:5][N:6]2[CH2:11][C:12]1([O:15][CH2:16][P:17](=[O:20])([OH:19])[OH:18])[CH2:14][CH2:13]1.C1([NH:27]C(N2CCOCC2)=NC2CCCCC2)CCCCC1.C(OCCl)(=O)C(C)(C)C.CO.Cl[CH2:54][Cl:55]>CN(C)C=O>[NH2:27][C:9]1[N:8]=[C:7]2[C:3]([N:4]=[CH:5][N:6]2[CH2:11][C:12]2([O:15][CH2:16][P:17](=[O:20])([OH:18])[OH:19])[CH2:13][CH2:14]2)=[C:54]([Cl:55])[N:10]=1参加物
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
The compound prepared in Example 1 (1.00 g) was dissolved in 150 ml of dry dimethylformamide, and 2.08 g (7.32 mmol) of N,N′-dicyclohexyl-4-morpholine-carboxamidine and 2.75 g (18.3 mmol) of chioromethyl pivalate were added thereto. When the reaction mixture became homogeneous after about 1 hour, it was stirred for 5 days at room temperature. The reaction solution was filtered, the filtrate was concentrated under reduced pressure, and the residue was fractionated with 50 ml of water and 50 ml of toluene to separate the organic layer. The aqueous layer was extracted twice with 50 ml of toluene. The combined organic layers were concentrated under reduced pressure. The residue was purified by column chromatography (eluent: methanol/dichloromethane=1/20, v/v) to give 0.59g (Yield 32%) of the title compound as a white solid.
後処理
- filtrationThe reaction solution was filtered
- concentrationthe filtrate was concentrated under reduced pressure
- customto separate the organic layer
- extractionThe aqueous layer was extracted twice with 50 ml of toluene
- concentrationThe combined organic layers were concentrated under reduced pressure
- customThe residue was purified by column chromatography (eluent
出典と根拠
- ORDレコード
- ord-a3b1c84bc88e40f0b038b4454a6fcfb4
- 出典データセット
- uspto-grants-2007_01
- 特許番号
- US07157448B2
関連ノート
読み込み中…